Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
23.87
-0.38 (-1.57%)
Nov 5, 2026, 3:19 PM AST

TADAWUL:2070 Cash Flow Statement

Millions SAR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
138.97184.3624.54-50.73-165.1426.45
Depreciation & Amortization
73.9886.8578.8476.1984.9383.66
Other Amortization
10.2710.275.865.823.894.44
Loss (Gain) From Sale of Assets
1.11-28.7-18.94-6.38-0.140.45
Asset Writedown & Restructuring Costs
3.362.6817.370.05--
Loss (Gain) From Sale of Investments
50.7621.337.0642.05-3.63-7.81
Loss (Gain) on Equity Investments
-17.97-24.35-22.73-20-20.44-11.41
Stock-Based Compensation
-0.541.711.18---
Provision & Write-off of Bad Debts
----10.05-13.86
Other Operating Activities
30.4513.16-73.92160.4111.05-6.84
Change in Accounts Receivable
-188.55-23.18-341.48-190.08172.6918.02
Change in Inventory
48.4925.78-49.6-143.03-76.5613.02
Change in Accounts Payable
-84.01-59.39116.37128.35-57.96-14.27
Change in Other Net Operating Assets
90.5861.89-105.58.22-44.37-3
Operating Cash Flow
151.44272.35-330.9610.87-99.386.71
Operating Cash Flow Growth
-16.17%----790.67%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-124.84-89.14-71.27-106.79-78.21-76.24
Sale of Property, Plant & Equipment
0.8539.5535.557.530.651.02
Sale (Purchase) of Intangibles
-11.75-10.44-31.01-5.94--1
Investment in Securities
-18.56-24.98-39.5-70.5525.89193.74
Other Investing Activities
--13.198.7536.323.97
Investing Cash Flow
-154.3-85.01-93.05-166.94484.63141.48

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,6121,2901,497-14.47
Long-Term Debt Repaid
--1,717-894.41-1,462-220.55-81.35
Lease Payments
-1.76-3.21-4.58-9.33-7.47-5.33
Net Debt Issued (Repaid)
21.13-104.78395.8234.61-220.55-66.87
Repurchase of Common Stock
-10.3--11.94-8--
Common Dividends Paid
-40.69--2.78-0.46-70.74-118.11
Other Financing Activities
-11.960.87--26.19-49.86-55.97
Financing Cash Flow
-41.82-103.91381.11-0.04-341.15-240.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2.8-1.671.95-16.15-38.58.35
Net Cash Flow
-41.8981.76-40.95-172.265.69-4.42

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
26.6183.21-402.23-95.92-177.5110.47
Free Cash Flow Growth
-77.66%-----
Free Cash Flow Margin
1.55%10.73%-23.91%-5.79%-12.48%0.72%
Free Cash Flow Per Share
0.221.53-3.37-0.80-1.480.09
Levered Free Cash Flow
-38.9296.42-353.9541.76-121.09-56.73
Unlevered Free Cash Flow
9.68152.06-299.7281.45-99.63-37.11
Free Cash Flow After Leases
24.84180-406.81-105.25-184.985.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
72.372.3108.1569.8233.4120.26
Cash Income Tax Paid
-----0.54
Change in Working Capital
-138.965.09-380.21-196.54-6.213.78